1. Home
  2. CPHI vs CHRO Comparison

CPHI vs CHRO Comparison

Compare CPHI & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • CHRO
  • Stock Information
  • Founded
  • CPHI N/A
  • CHRO 2002
  • Country
  • CPHI China
  • CHRO United States
  • Employees
  • CPHI N/A
  • CHRO N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • CHRO
  • Sector
  • CPHI Health Care
  • CHRO
  • Exchange
  • CPHI Nasdaq
  • CHRO Nasdaq
  • Market Cap
  • CPHI 4.0M
  • CHRO 3.8M
  • IPO Year
  • CPHI N/A
  • CHRO 2024
  • Fundamental
  • Price
  • CPHI $0.18
  • CHRO $2.79
  • Analyst Decision
  • CPHI
  • CHRO Strong Buy
  • Analyst Count
  • CPHI 0
  • CHRO 1
  • Target Price
  • CPHI N/A
  • CHRO N/A
  • AVG Volume (30 Days)
  • CPHI 1.8M
  • CHRO 2.5M
  • Earning Date
  • CPHI 11-13-2024
  • CHRO 02-20-2025
  • Dividend Yield
  • CPHI N/A
  • CHRO N/A
  • EPS Growth
  • CPHI N/A
  • CHRO N/A
  • EPS
  • CPHI N/A
  • CHRO N/A
  • Revenue
  • CPHI $5,544,620.00
  • CHRO N/A
  • Revenue This Year
  • CPHI N/A
  • CHRO N/A
  • Revenue Next Year
  • CPHI N/A
  • CHRO N/A
  • P/E Ratio
  • CPHI N/A
  • CHRO N/A
  • Revenue Growth
  • CPHI N/A
  • CHRO N/A
  • 52 Week Low
  • CPHI $0.13
  • CHRO $0.45
  • 52 Week High
  • CPHI $0.60
  • CHRO $6.00
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 42.59
  • CHRO 91.84
  • Support Level
  • CPHI $0.19
  • CHRO $0.81
  • Resistance Level
  • CPHI $0.24
  • CHRO $3.80
  • Average True Range (ATR)
  • CPHI 0.04
  • CHRO 0.49
  • MACD
  • CPHI -0.00
  • CHRO 0.22
  • Stochastic Oscillator
  • CPHI 0.00
  • CHRO 68.14

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Share on Social Networks: